Home » Topics » Regulatory » Patents

Patents
RSS

Kaken Pharmaceutical patents new ADAM inhibitors

Feb. 13, 2012

Sanofi prepares novel fibroblast growth factor receptor antagonists

Feb. 13, 2012

Pfizer and ICAgen identify new candidate analgesics

Feb. 10, 2012

New nematode serpin-based thrombin inhibitors discovered

Feb. 10, 2012

U.K. universities present new dust mite peptidase 1 inhibitors

Feb. 10, 2012

Sanofi synthesizes new fibroblast growth factor receptor antagonists

Feb. 10, 2012

Actelion Pharmceuticals discloses novel prostanoid DP2 receptor antagonists

Feb. 10, 2012

New E-NPP 2 inhibitors patented by Ono Pharmaceutical

Feb. 10, 2012

New compounds extracted from Cymbidium disclosed by Kawano Mericlone

Feb. 9, 2012

Cormus designs novel lipid-conjugated antibodies

Feb. 9, 2012

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...